Company
Editas Medicine, Inc. (EDIT)
Standardized SEC financial data for Editas Medicine, Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001650664 · NASDAQ · Biological Products, (No Diagnostic Substances).
Operating margin
-394.9%
Net margin
-395.0%
Revenue growth (YoY)
25.4%
Return on equity
-586.6%
Free cash flow
-$165.8M
Debt / equity
2.15×
Current ratio
3.54×
EPS (diluted)
$-1.80
Ratios for fiscal year 2025, standardized from SEC filings.
Income statement
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $90.7M | $25.5M | $19.7M | $78.1M | $32.3M | $40.5M |
| R&D expense |
Balance sheet
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $143.6M | $207.4M | $145.4M | $127.5M | $135.4M | $149.3M |
| Accounts receivable |
Cash flow
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$179.8M | -$163.8M | -$177.3M | -$132.2M | -$210.3M | -$165.2M |
| Capital expenditures |
Get EDIT data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/EDIT/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/EDIT/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"